Serum YKL-40 levels are altered in endometriosis
article
OA: closed
CC0
⤵ 13 in-corpus citations
AI-generated summary
Serum YKL-40 levels were significantly higher in women with endometriosis and positively correlated with disease stage, indicating its potential as a severity marker.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Endometriosis is traditionally defined as the presence of endometrial glands and stroma in ectopic locations, especially the pelvic peritoneum, ovaries and rectovaginal septum. YKL-40, a new biomarker of inflammation, is secreted by activated macrophages and neutrophils in different tissues with inflammation. Serum concentrations of YKL-40 are elevated in patients with diseases characterized by inflammation. We aimed to investigate the possible association between serum YKL-40 levels and endometriosis. A total number of 88 women were recruited for this case-control study. About 53 patients with surgically proven endometriosis were included, while 35 patients without endometriosis comprised the control group. Patients were classified as having minimal, mild, moderate and severe disease in accordance with the severity. Two new groups were formed by combining patients with minimal and mild disease (Stage 1-2) and with moderate and severe disease (Stage 3-4). Serum YKL-40 levels were statistically higher in the endometriotic group compared to control group (p:0.001). YKL-40 levels were significantly higher in Stage 3-4 group compared to Stage 1-2 group (p values 0.001) as well. Correlation analysis revealed a positive correlation between serum YKL-40 levels and the stage of the disease. YKL-40 may be utilized as a marker for determining the severity of endometriosis.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (33)
- Endometriosis via openalex
- EPIDEMIOLOGY OF ENDOMETRIOSIS via openalex
- Immunohistochemical expression of YKL-40 in peritoneal endometriosis via openalex
- Immunology of endometriosis via openalex
- Non-invasive diagnosis of endometriosis based on a combined analysis of six plasma biomarkers via openalex
- Oral contraceptives and endometriosis: the past use of oral contraceptives for treating severe primary dysmenorrhea is associated with endometriosis, especially deep infiltrating endometriosis via openalex
- Pathogenesis of endometriosis: natural immunity dysfunction or autoimmune disease? via openalex
- Questioning patients about their adolescent history can identify markers associated with deep infiltrating endometriosis via openalex
- Revised American Society for Reproductive Medicine classification of endometriosis: 1996 via openalex
- Role of cytokines in endometriosis via openalex
- Serum levels of VEGF and TNF-α and their association with C-reactive protein in patients with endometriosis via openalex
- The peritoneal environment in endometriosis via openalex
- The use of biochemical markers in the diagnosis of pelvic endometriosis via openalex
- W2001299275 via openalex
- W74156127 via openalex
- W2088634583 via openalex
- W2100571347 via openalex
- W2102558296 via openalex
- W2107332877 via openalex
- W2113504837 via openalex
- W2113817587 via openalex
- W2000149921 via openalex
- W1990643218 via openalex
- W1941240823 via openalex
- W2159228424 via openalex
- W2161104189 via openalex
- W2163239066 via openalex
- W4214953124 via openalex
- W1517373052 via openalex
- W2030232115 via openalex
- W2020707987 via openalex
- W2050307695 via openalex
- W2058365984 via openalex
Cited by (12)
- Endometriosis: A Cancer-Like Phenomenon 2026
- Chitinase-3-like protein 1, matrix metalloproteinase-9, and monocyte chemoattractant protein-1 as potential biomarkers and treatment targets of adenomyosis 2024
- The Abundance and Function of Neutrophils in the Endometriosis Systemic and Pelvic Microenvironment 2023
- Predictive Value of Serum YKL-40, Interleukin-37, and Cancer Antigen 125 Panel in Noninvasive Staging of Endometriosis 2023
- Endometriosis through an immunological lens: a pathophysiology based in immune dysregulation 2022
- May endocan be a new biomarker in the diagnosis of endometriosis? 2022
- Resistin and chemerin levels in follicular fluid of infertile women with endometriosis undergoing ICSI 2021
- Diagnostic Significance of Selected Serum Inflammatory Markers in Women with Advanced Endometriosis 2021
- Non-invasive diagnosis of endometriosis and moderate-severe endometriosis with serum CA125, endocan, YKL-40, and copeptin quadruple panel 2020
- Endometriosis Biomarkers in Body Fluids 2016
- Blood biomarkers for the non-invasive diagnosis of endometriosis 2016
- Update on Biomarkers for the Detection of Endometriosis 2015
Source provenance
- europepmc
- last seen: 2026-08-25T06:10:03.373225+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:18:35.150238+00:00
- unpaywall
- last seen: 2026-08-25T06:41:39.333708+00:00
License: CC0
· commercial use OK